Cytiva’s FlexFactory is a one-stop solution for equipment and services following single-use technology and a modular design tailored to the manufacturer’s needs.
Smart Connected Robotics, BD Kiestra™ IdentifA system, is designed to automate the preparation of microbiology bacterial identification testing.
Sidus Space, Inc. is constructing a new, state of the art cleanroom to support the production, testing and integration of the LizzieSat™ satellite constellation.
In line with the increased focus on the medical market segment, Coveris is taking a gigantic leap forward to modernize their medical packaging production facilities. With an extensive EUR 10 m investment program, Coveris strives to become best in class when it comes to process transparency, cleanliness and quality.
Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. While some upstream bioprocesses have been successfully automated, the final steps of downstream bioprocess, namely Fill-Finish, are often done manually with associated risks of contamination and user error.
The New York State Preferred Source Program for New Yorkers Who Are Blind (NYSPSP) continues to play a significant role in coordinating a strategic statewide response among its network of 10 affiliated nonprofit agencies, many of whom are providing essential products and services to help New York fight COVID-19.
Working with an international team of experts from universities on the forefront of air quality monitoring research, RESET® will be releasing a new air quality standard aimed at providing a framework for qualifying airborne particulate sensors – specifically optical particle counters – used for indoor and outdoor air quality monitoring.
Together these five companies have put together complex build solutions in response to the coronavirus. Individually they were the best for being the fastest of their building type, together they provide the complete solution within weeks, regardless of the requirements. RPM acts as the quarterback pulling in a team of top North American manufacturers with the specific purpose of delivering rapid deployment Community Response Facilities (CRF) that are designed to meet each community’s critical needs. If the location requires conversion of an existing structure, a large building shell that goes up quickly, or mobile secure steel buildings, together we have it covered.
Germfree delivered a 53-foot biocontainment cleanroom trailer to a major US pharmaceutical company where they will work on a COVID-19 vaccine. This is the first, of what is expected to be, many mobile laboratory spaces that will be delivered to scientists and organizations working on virus and antibody testing, vaccine development, research, and deployment solutions.
3M and Ford are collaborating on specific ways the companies can rapidly combine complementary capabilities and resources to help meet a surge in demand for personal protective equipment due to the COVID-19 outbreak.
Hygiene expert Christeyns expands its activities in the Life Science Division with the acquisition of Pliwa, German producer of disinfection products for hospitals and dental care. Although negotiated and signed before the corona crisis, the transaction – which was closed last Friday – will allow Christeyns to increase its production capacity of disinfectants for medical applications. As such the company hopes to provide even better support to the medical sector in these challenging times.
Medivant Health is currently building a 33,000-square-foot generic drug manufacturing facility in Chandler, Arizona. The first phase will create 10,000 square feet of manufacturing and laboratory space able to produce 40,000 vials of generic drug products every day. Medivant is a new Current Good Manufacturing Practice (CGMP) Manufacturer. Medivant is unique in that its sole purpose is to fill this generic drug shortage void. The facility is fully automated with minimal human intervention.